Publication | Closed Access

Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia

Hematological MalignancyMixed-phenotype Acute LeukemiaHematologyImmunologyPathologyLeukemic-cell Vla-4Stromal FibronectinAdult T-cell Leukemia-lymphomaMedicineCell BiologyTumor MicroenvironmentTumor BiologyMinimal Residual DiseaseMyeloid Neoplasia